Inflammation gets a bad name, but it’s not inherently destructive. Acute inflammation is your immune system’s first responder — a coordinated cascade of biochemical signals that sends healing cells to damaged tissue. The problem is when that response becomes chronic, unresolved, and low-grade. That’s when it shifts from protective to damaging, contributing to everything from joint pain to cardiovascular risk to metabolic dysfunction.
This is where omega-3 fatty acids come into the picture. Specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the long-chain fatty acids found in fatty fish and quality supplements. These compounds don’t just reduce inflammation — they actively resolve it through a process called inflammation resolution, which is a distinct biological pathway that was only fully characterised in the 1990s.
Resolution sounds passive, like inflammation just wearing off. It isn’t. It’s an active, enzyme-driven process involving specialised pro-resolving mediators (SPMs) — molecules synthesized from omega-3 fatty acids that actively signal immune cells to stand down, clear debris, and exit the scene. Without adequate omega-3 substrate, this resolution phase stalls. The inflammation doesn’t heal — it persists.
The implications are significant. In joint health, unresolved inflammation keeps synovial tissue swollen and sensitised, maintaining the pain cycle. Omega-3s don’t mask pain; they help the body complete the healing response so that pain signals stop being generated in the first place. Studies on joint mobility in older adults have shown consistent improvements with EPA/DHA supplementation, particularly in those with pre-existing inflammatory tone.
Cardiovascular research tells a similar story. Omega-3 fatty acids reduce the expression of adhesion molecules on blood vessel walls — the signals that recruit immune cells into arterial plaque. They also lower triglycerides, reduce blood pressure modestly, and make cell membranes more fluid, which affects everything from platelet aggregation to heart rhythm stability.
The key distinction is between plant-sourced omega-3 (ALA, found in flaxseed and chia) and marine-sourced omega-3 (EPA and DHA). ALA is a precursor — your body converts it to EPA and DHA, but the conversion rate is typically low, often under 10%. For meaningful inflammatory resolution support, direct EPA and DHA intake is far more reliable.
Most people don’t get adequate EPA and DHA from diet alone. Two to three servings of oily fish per week is the guideline — sardines, mackerel, salmon — but most people manage one at best. A quality omega-3 supplement that delivers meaningful EPA/DHA doses can fill that gap reliably.
If joint comfort and inflammation resolution are your goals, JointGen delivers a concentrated omega-3 formula designed to give your body the EPA and DHA it needs to complete the healing cycle. Move better, feel better — from the inside out.
EPA vs DHA: Different Molecules with Different Applications
EPA and DHA have distinct biological activities. EPA primarily serves as a precursor for eicosanoid production (generating less inflammatory prostaglandins than omega-6 derivatives) and has stronger effects on triglyceride reduction at doses of two to four grams per day. DHA is preferentially incorporated into neuronal and retinal cell membranes, critical for brain development and synaptic membrane fluidity. For cognitive protection, DHA is the more relevant omega-3.
Why the Omega-3 Index Is a Better Biomarker Than Intake
The omega-3 index (percentage of EPA and DHA in red blood cell membranes) is a better predictor of cardiovascular risk than dietary fish intake. An index above 8% is associated with a 40-50% reduction in sudden cardiac death risk. Below 4% correlates with substantially elevated cardiovascular risk. The index is available as a home test kit.
EPA vs DHA: Different Molecules with Different Applications
EPA and DHA have distinct biological activities. EPA primarily serves as a precursor for eicosanoid production (generating less inflammatory prostaglandins than omega-6 derivatives) and has stronger effects on triglyceride reduction at doses of two to four grams per day. DHA is preferentially incorporated into neuronal and retinal cell membranes, critical for brain development and synaptic membrane fluidity. For cognitive protection, DHA is the more relevant omega-3.
Why the Omega-3 Index Is a Better Biomarker Than Intake
The omega-3 index (percentage of EPA and DHA in red blood cell membranes) is a better predictor of cardiovascular risk than dietary fish intake. An index above 8% is associated with a 40-50% reduction in sudden cardiac death risk. Below 4% correlates with substantially elevated cardiovascular risk. The index is available as a home test kit.
Leave a Reply